Danaher to Solidify its Leadership in Bioprocessing - Post the Acquisition of the Biopharma Business of General Electric Life Sciences

Posted by MarketsandMarkets on Apr 15, 2019 9:54:19 PM

Danaher Corporation has entered into a definitive agreement with General Electric (GE) Company to acquire a very lucrative Biopharma business unit of GE Life Sciences. Biopharma unit of GE Life Sciences, is the leading provider of instruments, consumables, and software that support the research, discovery, process development and manufacturing workflows of biopharmaceutical drugs. The business comprises process chromatography hardware and consumables, cell culture media, single-use technologies, development instrumentation and consumables, and service.

Read More

Topics: healthcare, Bioprocessing

Guardant Health and AstraZeneca to develop companion diagnostics (CDx) and liquid biopsy tests

Posted by MarketsandMarkets on Dec 19, 2018 6:13:11 PM

On Dec 13, 2018 AstraZeneca, a global research based biopharmaceutical company, partnered with Guardant Health (US) for the development of CDx tests to commercialize AstraZeneca’s oncology portfolio including Tagrisso and Imfinzi. The CDx test is based on liquid biopsy platform supported by Guardant’s proprietary Digital Sequencing technology.

Read More

Topics: Medical Devices, blood-based companion diagnostics, cancer therapies, liquid biopsy, healthcare, tumor mutational burden

Recent Posts

Subscribe Here!

See all